Evaluation of Cocaine Effect on Endogenous Metabolites of HepG2 Cells Using Targeted Metabolomics.
Alanine
/ metabolism
Aspartic Acid
/ metabolism
Biomarkers
/ metabolism
Chromatography, Liquid
Cocaine
/ toxicity
Glutamic Acid
/ metabolism
Hep G2 Cells
Humans
Hydrophobic and Hydrophilic Interactions
Metabolic Networks and Pathways
Metabolome
/ drug effects
Metabolomics
/ methods
Multivariate Analysis
Tandem Mass Spectrometry
Taurine
/ analogs & derivatives
HepG2
cocaine toxicity
liquid chromatography
mass spectrometry
targeted metabolomics
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
29 Jul 2021
29 Jul 2021
Historique:
received:
05
07
2021
revised:
23
07
2021
accepted:
26
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
15
9
2021
Statut:
epublish
Résumé
Cocaine toxicity has been a subject of study because cocaine is one of the most common and potent drugs of abuse. In the current study the effect of cocaine on human liver cancer cell line (HepG2) was assessed. Cocaine toxicity (IC50) on HepG2 cells was experimentally calculated using an XTT assay at 2.428 mM. The metabolic profile of HepG2 cells was further evaluated to investigate the cytotoxic activity of cocaine at 2 mM at three different time points. Cell medium and intracellular material samples were analyzed with a validated HILIC-MS/MS method for targeted metabolomics on an ACQUITY Amide column in gradient mode with detection on a triple quadrupole mass spectrometer in multiple reaction monitoring. About 106 hydrophilic metabolites from different metabolic pathways were monitored. Multivariate analysis clearly separated the studied groups (cocaine-treated and control samples) and revealed potential biomarkers in the extracellular and intracellular samples. A predominant effect of cocaine administration on alanine, aspartate, and glutamate metabolic pathway was observed. Moreover, taurine and hypotaurine metabolism were found to be affected in cocaine-treated cells. Targeted metabolomics managed to reveal metabolic changes upon cocaine administration, however deciphering the exact cocaine cytotoxic mechanism is still challenging.
Identifiants
pubmed: 34361761
pii: molecules26154610
doi: 10.3390/molecules26154610
pmc: PMC8347943
pii:
doi:
Substances chimiques
Biomarkers
0
Taurine
1EQV5MLY3D
Aspartic Acid
30KYC7MIAI
Glutamic Acid
3KX376GY7L
hypotaurine
5L08GE4332
Cocaine
I5Y540LHVR
Alanine
OF5P57N2ZX
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : State Scholarships Foundation
ID : MIS-5000432
Références
Anal Bioanal Chem. 2014 Feb;406(5):1339-54
pubmed: 23912828
Anal Bioanal Chem. 2013 Jul;405(19):6299-306
pubmed: 23702902
Cell Biochem Funct. 2016 Oct;34(7):465-468
pubmed: 27570065
Anal Bioanal Chem. 2013 Feb;405(6):1959-68
pubmed: 23314481
Nucleic Acids Res. 1999 Jan 1;27(1):29-34
pubmed: 9847135
Mass Spectrom Rev. 2011 Sep-Oct;30(5):884-906
pubmed: 21384411
Anal Bioanal Chem. 2016 Feb;408(5):1467-74
pubmed: 26753977
Forensic Sci Int. 2018 Sep;290:137-145
pubmed: 30036735
Drug Metab Pharmacokinet. 2016 Feb;31(1):21-26
pubmed: 26613805
Neuroscience. 2012 Aug 30;218:196-205
pubmed: 22609933
J Pharmacol Toxicol Methods. 1995 Apr;33(2):113-20
pubmed: 7766918
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 15;1047:141-150
pubmed: 27884570
Neurochem Res. 2010 Feb;35(2):288-97
pubmed: 19757036
Brain Res. 2006 May 17;1089(1):44-54
pubmed: 16638611
Forensic Sci Int. 2017 May;274:83-90
pubmed: 28063635
Chem Biol Interact. 2018 Apr 1;285:1-7
pubmed: 29475069
J Proteome Res. 2020 Oct 2;19(10):4071-4081
pubmed: 32786683
Electrophoresis. 2015 Sep;36(18):2215-2225
pubmed: 26180020
Trends Mol Med. 2018 Feb;24(2):197-205
pubmed: 29397321
J Pharm Biomed Anal. 2017 Jun 5;140:313-321
pubmed: 28384623
Anal Chim Acta. 2012 Jan 20;711:7-16
pubmed: 22152789
Oxid Med Cell Longev. 2016;2016:8408479
pubmed: 26823954
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2101
pubmed: 27006508
PLoS One. 2020 Mar 23;15(3):e0227044
pubmed: 32203565
Bioanalysis. 2009 Aug;1(5):977-1000
pubmed: 21083066
Curr Med Chem. 2012;19(33):5601-6
pubmed: 22856659
Toxicol Mech Methods. 2015;25(6):494-500
pubmed: 26249365
Eur J Pharmacol. 2003 Dec 15;482(1-3):61-6
pubmed: 14660005
Sci Rep. 2018 Feb 9;8(1):2710
pubmed: 29426863
Open Pharmacol J. 2008;2(9):70-78
pubmed: 19568322
J Anal Toxicol. 2006 Oct;30(8):501-10
pubmed: 17132243
Psychopharmacology (Berl). 2009 Oct;206(3):479-89
pubmed: 19649617
Future Med Chem. 2012 Feb;4(2):163-75
pubmed: 22300096
J Lipid Res. 2012 Nov;53(11):2318-30
pubmed: 22904346
J Forensic Leg Med. 2014 Mar;23:37-43
pubmed: 24661704
Hepatology. 1990 Apr;11(4):646-51
pubmed: 2328957
Metabolites. 2019 Oct 16;9(10):
pubmed: 31623107
Brain Res Bull. 2009 May 29;79(3-4):215-8
pubmed: 19166917